Recommended therapies, including the administration of insulin with a pen or insulin pump, and achieving glycemic control with a glucometer, may be visible to the public, attract the attention of the environment and, thus, expose a person with T1D to assessment. This evidence concerns the gene INS and type 1 diabetes mellitus.